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Abstract 
Radiation Oncology, has changed a great deal, undergoing an innovation and 
technical development; there has been an evolution from conformal radiotherapy 
techniques (3D-CRT), through advanced modalities like intensity-modulated 
radiation therapy (IMRT) and next volumetric modulated arc therapy (VMAT). VMAT 
technique requires a dedicated QA (Quality Assurance) procedure for dosimetric 
verification of a planned dose distribution to check for the agreement between a 
dose distribution calculated by the Treatment Planning System (TPS) and the 
corresponding measured dose distribution. Since November 2010, in Radiation 
Therapy Department of “V. Fazzi” hospital in Lecce (Italy), 257 patients were treated 
with VMAT and the corresponding dose distribution were verified with the Delta4® 
diode array phantom. Parameters used in the comparison between calculated e 
measured dose are the dose agreement (DA), the distance to agreement (DTA) and 
the ?-index. The phantom measurements closely match the planned dose 
distributions in high and low dose-gradient region. 
 
Introduction 
Volumetric Modulated Arc Therapy (VMAT) 
is a new intensity-modulated radiation 
therapy (IMRT) technique that improves 
critical structures and healthy tissue sparing, 
in dramatically shorter treatment times all 
without comprising target coverage and 
patient safety.  
The sharp dose gradients found in VMAT, 
make critical the deviations between 
calculated and real dose distribution even if 
they are very small, especially in regions 
close to organs at risk; in addition, each 
VMAT plan is strictly tailored on the patient 
because the various  leaf position and leaf 
speed may be quite different, even case of 
target and organs at risk very similar, 
because it is dependent on multiple factors, 
each of them influencing dose effectively 
delivered to the patient. 
Complex radiotherapic treatment plans such 
as those obtained with VMAT require 
dosimetric verification before clinical 
delivery. 
Materials and methods 
In Radiation Therapy Department of “V. 
Fazzi” hospital in Lecce (Italy), 257 patients 
were treated with VMAT. 
In our institution, planned dose distribution 
is checked using the Delta4® diode array 
phantom. 
During verification process the planned 
treatment is transferred from the patient 
(Fig 1a) to the phantom (Fig 1b), the 
treatment plan is recalculated on a CT scan 
of the phantom and then the dose 
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distribution is measured using Delta4® 
device. 
 
Fig. 1a VMAT planned dose 
 
 
Fig. 1b recalculated VMAT dose on the Delta4? 
 
The Delta4® diode array phantom (Scandidos, 
Uppsala, Sweden) consists of 1069 p-type 
Silicon diodes in a crossed array inside a 
cylindrical polymethylmethacrylate (PMMA) 
phantom with associated a computer 
software that allows the user to compare the 
measured dose distribution for a complete 
treatment plan with the dose distribution 
predicted by the treatment planning system 
(Oncentra Masterplan®). The diodes are 
cylindrical, have an area of 0.0078 cm2 and 
are spaced at 0.5 cm intervals over the 
central 6 x 6 cm of the planes and at 1 cm 
intervals over the remainder of the central 20 
x 20 cm of the planes. The crossed planes are 
achieved by means of a main detector board 
which passes through the entire diameter of 
the phantom and two wing detector boards 
which are separated to allow the main 
detector board to pass between them. The 
phantom itself has a diameter of 22 cm and 
length of 40 cm (Figure 2). 
The device records measured dose in relation 
to the individual accelerator pulses by using a 
trigger signal from the accelerator, facilitating 
time-dependent four-dimensional 
applications. Gantry angle is independently 
sensed by means of an inclinometer attached 
to the gantry or accelerator head. This allows 
the device to identify which control point of a 
dynamic arc delivery is being delivered, so 
that the measured dose can be associated 
with this control point, and the appropriate 
correction for gantry angle applied. 
When the measure with the Delta4® has been 
performed, the agreement between 
calculated and measured dose distributions 
must be analyzed. 
A qualitative check of the agreement is 
usually performed by dose profiles along 
selected lines or isodose comparisons. 
 
 
Fig.2 Delta4® phantom 
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If quantitative comparisons are required, the 
choice of the correct parameters to be 
employed is critical.  
In standard techniques, the most important 
parameters are: “dose agreement” or DA and 
“distance to agreement” or DTA. 
DA is the percentage or absolute difference 
between measured and calculated dose, 
unfortunately it is not suitable for high dose 
gradient region, where even small spatial 
errors may lead to large but not significant 
errors. So in high dose gradient regions it is 
used the DTA, defined as the minimum 
distance, in the plane, between a measured 
point and the nearest point in the calculated 
dose distribution that has the same dose. It is 
defined 3mm as distance limit.  
It is important to underline that DTA depend 
on the choice of the correct common 
coordinate system between measured and 
calculated dose, otherwise results are not 
significant. 
The DTA and the DA% are quantitative tools 
but they still have important limitations when 
applied to IMRT dose distributions. 
To overcome all these problems, a new 
parameter (?-index) that it includes in a single 
data set DA% and DTA has been introduced. 
The ?–index is defined as follows: given a 
point in the reference distribution, rr , and 
the relative dose Dr, an “acceptance 
ellipsoid” for point rr is defined by : 
 
 
 
?dM e ?rM  the acceptance criteria for 
distance e dose  
?r is the distance between the measured 
point rm and a point rc chosen in calculated 
dose distribution  
?d is the corresponding dose difference. 
As a general rule, acceptance criteria of 3 % 
dose difference and 3 mm distance to 
agreement are adopted and more than 90%-
÷95% of points passing the chose criterion. 
 
Results 
All 257 VMAT treatment plans were 
recalculated on a CT scan of Delta4®  phantom 
and the corresponding dose distributions 
were verified with the Delta4® diode array 
phantom. 
All plans were analyzed using the three 
parameter %DA (limit 3%), DTA (limit 3%), 
(limit 3 mm), and ?-index with the 3% dose 
tolerance and 3 mm distance to agreement in 
relation to the treatment planning system. 
The gamma criterion was considered fulfilled 
if γ < 1 in at least 90÷95% of the points. 
Results confirmed a good agreement 
between the two distribution with high and 
conformed dose to the target and low dose 
to the organ at risk. 
Fig.3 shows Delta4 output for head and neck 
cases, the planned dose distribution in 
grayscale and the measured dose in color 
over the wing detector boards (at left) and 
the main detector board (at right) and the 
histograms of %DA, DTA, and ?-index are in 
reported. 
 
Fig. 3 Delta4® software analysis 
 
Furthermore because the software shows the 
matrix of ? statistics points (blue pass (? <1) 
and red fall (? >1)), it was also possible to 
investigate a plan respect the position of the 
“red points” and the organ at risk. 
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Fig. 4a Example of  ??matrix in  axial plan 
 
 
Fig.4b Example of ??matrix in coronal plan 
 
Discussions and Conclusions 
Verification of a planned dose distribution is 
a complex and time consuming procedure 
because all described parameters DTA, %DA 
and ?-index are very important and using  
only one of them is not enough to accept a 
treatment plan.  
The plan must be investigated using every 
instrument and always taking in 
consideration the clinical meaning of 
eventual disagreement: for example a plan 
con y < 1 in 90% of the analyzed points is not 
a good plan, but it is necessary verify the 
distribution of the points con y > 1; if they are 
distant from target and organ at risk the plan 
can became acceptable. 
Although Delta4 appears a straightforward 
device for measuring dose and  allows 
measure in real time, it is a complex device 
and careful quality assurance before its use is 
therefore recommended. 
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